MARCO ALFIO CUTULI

Dr. MARCO ALFIO CUTULI

Department of Health and Medical Sciences “V. Tiberio” University of Molise Via de Sanctis 3, III Ed. Polifunzionale, 8600 Campobasso (CB) Molise Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Virulence
Verified
Journal Article
Open access
MCMARCO ALFIO CUTULI
MARCO ALFIO CUTULI
GPGiulio Petronio Petronio
Giulio Petronio Petronio
FVFranca Vergalito
Franca Vergalito
IMIrene Magnifico
Irene Magnifico
LPLaura Pietrangelo
Laura Pietrangelo
Roberto (Maria Antonio) Di MarcoRoberto (Maria Antonio) Di Marco
Roberto (Maria Antonio) Di Marco
A greater ethical conscience, new global rules and a modified perception of ethical consciousness entail a more rigorous control on utilizations of vertebrates for in vivo studies. To cope with this new scenario, numerous alternatives to rodents have been proposed. Among these, the greater wax moth Galleria mellonella had a preponderant role, especially in the microbiological field, as demonstrated by the growing number of recent scientific publications. The reasons for its success must be sought in its peculiar characteristics such as the innate immune response mechanisms and the ability to grow at a temperature of 37°C. This review aims to describe the most relevant features of G. mellonella in microbiology, highlighting the most recent and relevant research on antibacterial strategies, novel drug tests and toxicological studies. Although solutions for some limitations are required, G. mellonella has all the necessary host features to be a consolidated in vivo model host.

26 December 2019 in Open Medicine
Verified
Journal Article
Open access
PDF file
FVFranca Vergalito
Franca Vergalito
LPLaura Pietrangelo
Laura Pietrangelo
GPGiulio Petronio Petronio
Giulio Petronio Petronio
FCFederica Colitto
Federica Colitto
MCMARCO ALFIO CUTULI
MARCO ALFIO CUTULI
Roberto (Maria Antonio) Di MarcoRoberto (Maria Antonio) Di Marco
Roberto (Maria Antonio) Di Marco
The healthcare-associated infections (HCAIs) occur in patients both in nosocomial environments and in community. More often HCAIs are associated to the use of medical devices and bacterial biofilm development on these equipments. Due to the clinical and economic relevance of this topic, new strategies for the treatment of infections caused by biofilm proliferation are unceasingly searched by scientists. The present study investigated the role of vitamin E to reduce the biofilm formation for a larger panel of human pathogens, including strains of Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Acinetobacter baumannii, Pseudomonas aeruginosa and Pseudomonas putida. This potential activity was tested by placing a preparation of vitamin E (α-Tocopheryl acetate) as interface between the bacterial culture and the polystyrene walls of a 96 well plate at different concentrations of glucose, used as a biofilm enhancer. The Staphylococcus genus was further investigated by spreading the vitamin E on a silicone catheter lumen and evaluating its influence on the bacterial colonization. From our results, vitamin E has been able to interfere with bacterial biofilm and prevent in vitro biofilm formation. Furthermore, the ability of Staphylococcus aureus and Staphylococcus epidermidis to colonize the catheter surface decreased as a result of vitamin E application.

22 November 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
IMIrene Magnifico
Irene Magnifico
GPGiulio Petronio Petronio
Giulio Petronio Petronio
NVNoemi Venditti
Noemi Venditti
MCMARCO ALFIO CUTULI
MARCO ALFIO CUTULI
LPLaura Pietrangelo
Laura Pietrangelo
Roberto (Maria Antonio) Di MarcoRoberto (Maria Antonio) Di Marco
Roberto (Maria Antonio) Di Marco
Atopic dermatitis (AD) is a pathological skin condition with complex aetiological mechanisms that are difficult to fully understand. Scientific evidence suggests that of all the causes, the impairment of the skin barrier and cutaneous dysbiosis together with immunological dysfunction can be considered as the two main factors involved in this pathological skin condition. The loss of the skin barrier function is often linked to dysbiosis and immunological dysfunction, with an imbalance in the ratio between the pathogen Staphylococcus aureus and/or other microorganisms residing in the skin. The bibliographic research was conducted on PubMed, using the following keywords: ‘atopic dermatitis’, ‘bacterial therapy’, ‘drug delivery system’ and ‘alternative therapy’. The main studies concerning microbial therapy, such as the use of bacteria and/or part thereof with microbiota transplantation, and drug delivery systems to recover skin barrier function have been summarized. The studies examined show great potential in the development of effective therapeutic strategies for AD and AD-like symptoms. Despite this promise, however, future investigative efforts should focus both on the replication of some of these studies on a larger scale, with clinical and demographic characteristics that reflect the general AD population, and on the process of standardisation, in order to produce reliable data.

29 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
GPGiulio Petronio Petronio
Giulio Petronio Petronio
MCMARCO ALFIO CUTULI
MARCO ALFIO CUTULI
IMIrene Magnifico
Irene Magnifico
NVNoemi Venditti
Noemi Venditti
LPLaura Pietrangelo
Laura Pietrangelo
Roberto (Maria Antonio) Di MarcoRoberto (Maria Antonio) Di Marco
Roberto (Maria Antonio) Di Marco
Berberine is an alkaloid of the protoberberine type used in traditional oriental medicine. Its biological activities include documented antibacterial properties against a wide variety of microorganisms; nonetheless, its use against Escherichia coli strains isolated from urinary infections has not yet been widely investigated in vivo. The emergence of antimicrobial resistance requires new therapeutic approaches to ensure the continued effectiveness of antibiotics for the treatment and prevention of urinary infections. Moreover, uropathogenic Escherichia coli (UPEC) has developed several virulence factors and resistance to routine antibiotic therapy. To this end, several in vitro and in vivo tests were conducted to assess the activity of berberine on uropathogenic E. coli strains. Galleria mellonella as an infection model was employed to confirm the in vivo translatability of in vitro data on berberine activity and its influence on adhesion and invasion proprieties of E. coli on human bladder cells. In vitro pre-treatment with berberine was able to decrease the adhesive and invasive UPEC ability. In vivo treatment increased the larvae survival infected with UPEC strains and reduced the number of circulating pathogens in larvae hemolymph. These preliminary findings demonstrated the efficacy and reliability of G. mellonella as in vivo model for pre-clinical studies of natural substances.

7 October 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
GPGiulio Petronio Petronio
Giulio Petronio Petronio
LPLaura Pietrangelo
Laura Pietrangelo
MCMARCO ALFIO CUTULI
MARCO ALFIO CUTULI
IMIrene Magnifico
Irene Magnifico
NVNoemi Venditti
Noemi Venditti
Roberto (Maria Antonio) Di MarcoRoberto (Maria Antonio) Di Marco
Roberto (Maria Antonio) Di Marco
In recent years, the scientific community’s interest in T. molitor as an insect model to investigate immunity and host-pathogen interactions has considerably increased. The reasons for this growing interest could be explained by the peculiar features of this beetle, which offers various advantages compared to other invertebrates models commonly used in laboratory studies. Thus, this review aimed at providing a broad view of the T. molitor immune system in light of the new scientific evidence on the developmental/tissue-specific gene expression studies related to microbial infection. In addition to the well-known cellular component and humoral response process, several studies investigating the factors associated with T. molitor immune response or deepening of those already known have been reported. However, various aspects remain still less understood, namely the possible crosstalk between the immune deficiency protein and Toll pathways and the role exerted by T. molitor apolipoprotein III in the expression of the antimicrobial peptides. Therefore, further research is required for T. molitor to be recommended as an alternative insect model for pathogen-host interaction and immunity studies.

27 November 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MPMaria Cristina Petralia
Maria Cristina Petralia
EMEmanuela Mazzon
Emanuela Mazzon
MBMaria Sofia Basile
Maria Sofia Basile
MCMARCO ALFIO CUTULI
MARCO ALFIO CUTULI
Roberto (Maria Antonio) Di MarcoRoberto (Maria Antonio) Di Marco
Roberto (Maria Antonio) Di Marco
KMKatia Mangano
Katia Mangano
The emerging role of epigenetics in the pathogenesis of autoimmune diseases has recently attracted much interest on the possible use of epigenetic modulators for the prevention and treatment of these diseases. In particular, we and others have shown that drugs that inhibit DNA methylation, such as azacitidine (AZA) and decitabine (DAC), already used for the treatment of acute myeloid leukemia, exert powerful beneficial effects in rodent models of type 1 diabetes, multiple sclerosis, and Guillain Barrè syndrome. Along this line of research, we have presently studied the effects of DAC in a murine model of rheumatoid arthritis induced by type II collagen and have demonstrated that DAC administration was associated with a significant amelioration of the clinical condition, along with in vivo and ex vivo modification of the immunological profile of the so-treated mice, that exhibited a diminished production of Th1 and Th17 pro-inflammatory cytokines and reduction of anti-type II collagen autoantibodies.